29 related articles for article (PubMed ID: 37721395)
1. Somatic SF3B1 hotspot mutation in prolactinomas.
Li C; Xie W; Rosenblum JS; Zhou J; Guo J; Miao Y; Shen Y; Wang H; Gong L; Li M; Zhao S; Cheng S; Zhu H; Jiang T; Ling S; Wang F; Zhang H; Zhang M; Qu Y; Zhang Q; Li G; Wang J; Ma J; Zhuang Z; Zhang Y
Nat Commun; 2020 May; 11(1):2506. PubMed ID: 32427851
[TBL] [Abstract][Full Text] [Related]
2. Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas.
McAndrew J; Paterson AJ; Asa SL; McCarthy KJ; Kudlow JE
Endocrinology; 1995 Oct; 136(10):4479-88. PubMed ID: 7664668
[TBL] [Abstract][Full Text] [Related]
3. A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression.
Sbaffone M; Jaffrain-Rea ML; Cappabianca L; Carbonara F; Gianno F; Feola T; Ruggieri M; Zelli V; Maccarone R; Guadagni S; Clementi M; Arcella A; Esposito V; Carozza G; Martelli I; Farina AR; Mackay AR
Biology (Basel); 2024 Mar; 13(3):. PubMed ID: 38534441
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.
Dzialach L; Sobolewska J; Zak Z; Respondek W; Witek P
Front Endocrinol (Lausanne); 2024; 15():1338345. PubMed ID: 38370355
[TBL] [Abstract][Full Text] [Related]
5. Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors.
Torres-Morán M; Franco-Álvarez AL; Rebollar-Vega RG; Hernández-Ramírez LC
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067388
[TBL] [Abstract][Full Text] [Related]
6. Pathology of prolactinomas: any predictive value?
Lopes MBS
Pituitary; 2020 Feb; 23(1):3-8. PubMed ID: 31641970
[TBL] [Abstract][Full Text] [Related]
7. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
[TBL] [Abstract][Full Text] [Related]
8. Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia.
Faraoni EY; Abeledo Machado AI; Pérez PA; Marcial López CA; Camilletti MA; Peña-Zanoni M; Rulli SB; Gutiérrez S; Díaz-Torga G
J Endocrinol; 2020 Feb; 244(2):415-429. PubMed ID: 32395971
[TBL] [Abstract][Full Text] [Related]
9. The SF3B1
Guo J; Li C; Fang Q; Liu Y; Wang D; Chen Y; Xie W; Zhang Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):26. PubMed ID: 35039052
[TBL] [Abstract][Full Text] [Related]
10. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours.
Simon J; Perez-Rivas LG; Zhao Y; Chasseloup F; Lasolle H; Cortet C; Descotes F; Villa C; Baussart B; Burman P; Maiter D; von Selzam V; Rotermund R; Flitsch J; Thorsteinsdottir J; Jouanneau E; Buchfelder M; Chanson P; Raverot G; Theodoropoulou M
Eur J Endocrinol; 2023 Sep; 189(3):372-378. PubMed ID: 37721395
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours.
Trouillas J; Delgrange E; Wierinckx A; Vasiljevic A; Jouanneau E; Burman P; Raverot G
Neuroendocrinology; 2019; 109(1):70-76. PubMed ID: 30943495
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
